Royal Bank of Canada
HQL

Royal Bank of Canada’s abrdn Life Sciences Investors HQL Stock Holding History

Royal Bank of Canada’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97M Buy
121,240
+17,152
+16% +$287K ﹤0.01% 3105
2025
Q4 		$1.75M Buy
104,088
+24,843
+31% +$417K ﹤0.01% 3231
2025
Q3 		$1.23M Sell
79,245
-372,091
-82% -$5.09M ﹤0.01% 3807
2025
Q2 		$5.78M Buy
451,336
+377,861
+514% +$4.66M ﹤0.01% 2453
2025
Q1 		$934K Buy
73,475
+25,542
+53% +$346K ﹤0.01% 3542
2024
Q4 		$630K Sell
47,933
-2,176
-4% -$31.4K ﹤0.01% 3898
2024
Q3 		$756K Buy
50,109
+5,231
+12% +$79.2K ﹤0.01% 3763
2024
Q2 		$636K Buy
44,878
+1,576
+4% +$21.3K ﹤0.01% 3821
2024
Q1 		$590K Sell
43,302
-1,230
-3% -$17K ﹤0.01% 3850
2023
Q4 		$599K Buy
44,532
+3,921
+10% +$48.2K ﹤0.01% 4115
2023
Q3 		$507K Buy
40,611
+7,717
+23% +$101K ﹤0.01% 4019
2023
Q2 		$446K Buy
32,894
+1,284
+4% +$17.7K ﹤0.01% 4036
2023
Q1 		$441K Sell
31,610
-6,365
-17% -$91K ﹤0.01% 3970
2022
Q4 		$539K Buy
37,975
+4,933
+15% +$71.5K ﹤0.01% 4048
2022
Q3 		$451K Sell
33,042
-4,657
-12% -$69.6K ﹤0.01% 4120
2022
Q2 		$536K Buy
37,699
+1,353
+4% +$20.4K ﹤0.01% 4033
2022
Q1 		$601K Sell
36,346
-1,394
-4% -$24K ﹤0.01% 4123
2021
Q4 		$726K Buy
37,740
+3,896
+12% +$78.4K ﹤0.01% 4139
2021
Q3 		$704K Sell
33,844
-5,489
-14% -$117K ﹤0.01% 4031
2021
Q2 		$843K Buy
39,333
+1,170
+3% +$23.6K ﹤0.01% 3812
2021
Q1 		$752K Buy
38,163
+2,506
+7% +$51.6K ﹤0.01% 3838
2020
Q4 		$704K Sell
35,657
-5,019
-12% -$92.8K ﹤0.01% 3831
2020
Q3 		$715K Buy
40,676
+9,079
+29% +$163K ﹤0.01% 3548
2020
Q2 		$567K Sell
31,597
-6,797
-18% -$117K ﹤0.01% 3669
2020
Q1 		$575K Buy
38,394
+2,770
+8% +$45.4K ﹤0.01% 3488
2019
Q4 		$621K Buy
35,624
+556
+2% +$9.13K ﹤0.01% 3813
2019
Q3 		$530K Buy
35,068
+4,344
+14% +$69.6K ﹤0.01% 3805
2019
Q2 		$518K Sell
30,724
-249
-0.8% -$4.1K ﹤0.01% 3839
2019
Q1 		$530K Buy
30,973
+9,008
+41% +$156K ﹤0.01% 3686
2018
Q4 		$331K Buy
21,965
+5,256
+31% +$92.6K ﹤0.01% 4018
2018
Q3 		$341K Sell
16,709
-1,190
-7% -$23.7K ﹤0.01% 4147
2018
Q2 		$336K Sell
17,899
-3,009
-14% -$56.6K ﹤0.01% 4087
2018
Q1 		$402K Sell
20,908
-1,959
-9% -$39.2K ﹤0.01% 3853
2017
Q4 		$449K Sell
22,867
-6,176
-21% -$124K ﹤0.01% 3867
2017
Q3 		$624K Buy
29,043
+9,693
+50% +$206K ﹤0.01% 3620
2017
Q2 		$403K Buy
19,350
+2,060
+12% +$41.6K ﹤0.01% 3828
2017
Q1 		$335K Buy
17,290
+3,235
+23% +$59.9K ﹤0.01% 3963
2016
Q4 		$239K Buy
14,055
+2,351
+20% +$41.3K ﹤0.01% 4366
2016
Q3 		$219K Sell
11,704
-1,873
-14% -$35.3K ﹤0.01% 4370
2016
Q2 		$234K Buy
13,577
+1,472
+12% +$27.2K ﹤0.01% 4297
2016
Q1 		$217K Sell
12,105
-4,212
-26% -$76.5K ﹤0.01% 4310
2015
Q4 		$385K Buy
16,317
+2,966
+22% +$73.6K ﹤0.01% 4015
2015
Q3 		$300K Sell
13,351
-1,349
-9% -$37.8K ﹤0.01% 3986
2015
Q2 		$415K Sell
14,700
-8,843
-38% -$245K ﹤0.01% 3786
2015
Q1 		$649K Sell
23,543
-5,290
-18% -$144K ﹤0.01% 3267
2014
Q4 		$717K Sell
28,833
-906
-3% -$21.7K ﹤0.01% 3224
2014
Q3 		$657K Buy
29,739
+10,592
+55% +$230K ﹤0.01% 3200
2014
Q2 		$397K Buy
19,147
+3,162
+20% +$66.4K ﹤0.01% 3635
2014
Q1 		$348K Sell
15,985
-807
-5% -$18K ﹤0.01% 3635
2013
Q4 		$343K Buy
16,792
+326
+2% +$6.32K ﹤0.01% 3710
2013
Q3 		$317K Sell
16,466
-2,728
-14% -$52.2K ﹤0.01% 3747
2013
Q2 		$341K Buy
+19,194
New +$347K ﹤0.01% 3468

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada's HQL Position: Q1 2026 in Review

Royal Bank of Canada increased its abrdn Life Sciences Investors (HQL) stake by 16% in Q1 2026, buying an estimated $287K and bringing the position to 121,240 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #3105.

Royal Bank of Canada first reported a position in HQL in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.78M in Q2 2025. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Royal Bank of Canada held 121,240 shares of abrdn Life Sciences Investors worth $1.97M as of Q1 2026.
  • Royal Bank of Canada bought 17,152 abrdn Life Sciences Investors shares in Q1 2026, an estimated $287K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3105 holding.
  • Royal Bank of Canada first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's abrdn Life Sciences Investors position peaked at $5.78M in Q2 2025.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.